Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Josef Ressel Centre Perinatal Programming

Josef Ressel Centre for the Investigation of Early Life Metabolic Programming Regarding Dispositions of Obesity

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Background: Metabolic imprinting through early childhood nutrition seems to play an important role in the aetiology of obesity. Overweight at age two and later in life is associated with excessive weight gain as early as three months of age. Breastfeeding in the first year of life appears to be protective against obesity development. Objective: of the "Josef Ressel Centre for Early Life Metabolic Programming of Dispositions of Obesity" is to identify maternal and infant predictors of metabolic risk of obesity. The main considerations of modifiable factors are early infant nutrition, 24-hours-drinking-volume, the velocity of infant weight gain, in relation to infant fat mass and fat free mass, to biomarker and to the nutritional status of the mother. A second focus is put on maternal feeding style, infant eating behaviour and the identification of satiety cues. Multi-Study design: a monocentric prospective longitudinal cohort of 100 healthy, non-obese, non-smoking pregnant mothers and their term, normal birthweight, singleton babies. Mothers and exclusively breastfed versus exclusively formula fed children (at 16 weeks) will be examined at 36 weeks of pregnancy, 4 - 8 - 12 and 16 weeks of life, follow-up at 1 and 2 years of life. Methods: four weighing protocols between 4th and 16th week of life, feeding diary, anthropometric data measurement of mother and child, child fat mass index by air displacement plethysmograph. Macronutrient and energy content of the breast milk will be analysed by MIRIS™. Well-defined biomarkers of oxidative stress and inflammation, lipid profile, adipokines, insulin, as well as micro- und macronutrients will be analysed as meaningful indicators regarding the development of obesity and/or the metabolic syndrome in newborns. Samples, such as plasma, urine, saliva, and stool of the mothers and children will be examined with High Performance Liquid Chromatography, High Performance Gas Chromatography, Mass Spectrometry, Enzyme-Linked Immunosorbent Assay (ELISA) and more. Also questionnaires for the evaluation of the maternal milk feeding style are used as well as the Baby and Child Eating and Behaviour Questionnaire at 16 weeks, 1 and 2 years. A semi-automatic recognition of infants' satiety cues during feeding will be performed. The recording environment includes video cameras and microphones, a pulse oximeter, etc. All signals are synchronously recorded with the aid of the hardware and software infrastructure.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Pregnancy or mother in puerperium 2. Delivery of baby at 37+0 to 41+6 gestational age 3. Legal age (18 years old), age limit 50 years 4. Written consent of test person after having been informed 5. BMI ≥ 18.5 kg/m² to \< 30 kg/m² 6. Negative result of oGTT (oral glucose tolerance test) during pregnancy 7. Birth weight of baby 2.5-4.5 kg 8. Non-smoker since knowledge of pregnancy 9. Very good knowledge of German language and Caucasian 10. Exclusive breastfeeding or exclusive formula feeding at MR 2 (4th week of life) Who Should NOT Join This Trial: 1. Birth before 37+0 week of pregnancy (WoP) or after the 41+6 WoP 2. Multiple pregnancy 3. Children with serious congenital malformations of - Nervous system - Mouth, throat, neck - Circulation system - Respiratory tract - Gastrointestinal tract - Urogenital tract - Chromosomal aberrations 4. Diseases or hospitalization or intensive medical care of child during neonatal period 5. Hereditary metabolic diseases of child - Hereditary disorders of fat metabolism (MCHAD: Medium Chain Acyl-CoA Dehydrogenase Deficiency, LCHAD: Long Chain Acyl-CoA Dehydrogenase Deficiency, VLCHAD: Very Long Chain Acyl-CoA Dehydrogenase Deficiency) - Hereditary disorders of amino acid metabolism (PKU: Phenylketonuria) - Hereditary disorders of carbohydrate metabolism (Glycogenosis, Galactosemia, Hereditary fructose intolerance, Diabetes mellitus Type 1) 6. Drug (tobacco) abuse 7. Mental illnesses that have to be treated with medicaments 8. Metabolic or autoimmune conditions (where your immune system attacks your own body)s of mother 9. Complications at birth (blood loss \> 1000 ml or eclampsia) 10. Pre-conceptional diabetes (type 1 or 2) 11. Celiac disease and/or wheat protein allergy of mother 12. Breast surgery and/or hypomastia 13. Mixed feeding at MR 2 (4th week of life) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Pregnancy or mother in puerperium 2. Delivery of baby at 37+0 to 41+6 gestational age 3. Legal age (18 years old), age limit 50 years 4. Written consent of test person after having been informed 5. BMI ≥ 18.5 kg/m² to \< 30 kg/m² 6. Negative result of oGTT (oral glucose tolerance test) during pregnancy 7. Birth weight of baby 2.5-4.5 kg 8. Non-smoker since knowledge of pregnancy 9. Very good knowledge of German language and Caucasian 10. Exclusive breastfeeding or exclusive formula feeding at MR 2 (4th week of life) Exclusion Criteria: 1. Birth before 37+0 week of pregnancy (WoP) or after the 41+6 WoP 2. Multiple pregnancy 3. Children with serious congenital malformations of * Nervous system * Mouth, throat, neck * Circulation system * Respiratory tract * Gastrointestinal tract * Urogenital tract * Chromosomal aberrations 4. Diseases or hospitalization or intensive medical care of child during neonatal period 5. Hereditary metabolic diseases of child * Hereditary disorders of fat metabolism (MCHAD: Medium Chain Acyl-CoA Dehydrogenase Deficiency, LCHAD: Long Chain Acyl-CoA Dehydrogenase Deficiency, VLCHAD: Very Long Chain Acyl-CoA Dehydrogenase Deficiency) * Hereditary disorders of amino acid metabolism (PKU: Phenylketonuria) * Hereditary disorders of carbohydrate metabolism (Glycogenosis, Galactosemia, Hereditary fructose intolerance, Diabetes mellitus Type 1) 6. Drug (tobacco) abuse 7. Mental illnesses that have to be treated with medicaments 8. Metabolic or autoimmune diseases of mother 9. Complications at birth (blood loss \> 1000 ml or eclampsia) 10. Pre-conceptional diabetes (type 1 or 2) 11. Celiac disease and/or wheat protein allergy of mother 12. Breast surgery and/or hypomastia 13. Mixed feeding at MR 2 (4th week of life)

Treatments Being Tested

BEHAVIORAL

observation

Observation of growth, infant bodycomposition, 24h-drinkingvolume

Locations (1)

FH Joanneum, university of applied sciences
Graz, Styria, Austria